melanoma

75 проекта

H2020Индивидуална стипендия2020–2022Израел

MelImmuneOrg · Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy

H2020Индивидуална стипендия2020–2022Нидерландия

UNPACK PD-L1 · Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells

H2020Индивидуална стипендия2019–2021Дания

ARGONAUT · from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy

H2020Индивидуална стипендия2019–2021Белгия

INHuMAN · Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma

H2020Индивидуална стипендия2018–2020Нидерландия

KILNEV · Killing Senescent Cells as a Novel Method to Eliminate Nevi

H2020Индивидуална стипендия2018–2020Дания

UTILIUM · Unraveling The Immune Landscape In Uveal Melanoma

H2020Индивидуална стипендия2018–2020Испания

IMMUNOMARK · Omics integration for precision cancer immunotherapy

H2020Индивидуална стипендия2018–2020Испания

CINK · Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers

H2020Индивидуална стипендия2018–2020Португалия

TRIBBLES · Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma

H2020Индивидуална стипендия2017–2021Испания

METMEL · Long range-acting drivers of premetastatic niches in melanoma

H2020Индивидуална стипендия2017–2019Ирландия

SAMNets · Investigation of adaptive design and rewiring of Survival-Apoptosis-Mitogenic (SAM) signalling transduction network

H2020Индивидуална стипендия2017–2019Израел

SCALTIE · Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy

H2020Обмен на изследователи2017–2023Испания

MAGNAMED · Novel magnetic nanostructures for medical applications

18 партньори · 8 държави

H2020Индивидуална стипендия2017–2018Испания

DLL4-LVN · Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma

H2020Индивидуална стипендия2017–2019Франция

MCNTMTDC · Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours

H2020Индивидуална стипендия2016–2018Обединеното кралство

GENMETASTEM · GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS

H2020Докторантска мрежа2015–2019Ирландия

TRAIN-ERS · Endoplasmic Reticulum Stress in Health and Disease

18 партньори · 11 държави

H2020Докторантска мрежа2015–2019Обединеното кралство

MELGEN · MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival

6 партньори · 5 държави

H2020Докторантска мрежа2015–2019Нидерландия

VIRION · Viruses, Immune stimulation and RNA Interference in Oncology Network

9 партньори · 4 държави

H2020Индивидуална стипендия2015–2017Дания

MatrixMacrophages · Matrix degrading macrophages in cancer growth and invasion

H2020Индивидуална стипендия2015–2017Обединеното кралство

MELANOPARK · Investigating the LRRK2-melanin connection through phosphoproteomics of isogenic melanoma cells

H2020Индивидуална стипендия2015–2017Обединеното кралство

Tolltum · Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment

H2020Обмен на изследователи2014–2018Германия

SAGE-CARE · SemAntically integrating Genomics with Electronic health records for Cancer CARE

5 партньори · 5 държави

H2020Докторантска мрежа2014–2018Ирландия

MEL-PLEX · Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine

20 партньори · 11 държави